Trinity Biotech plc, a biotechnology company specializing in human diagnostics and diabetes management, announced it has secured an additional $4 million in debt financing from Perceptive Advisors.
Trinity Biotech plc announced a significant step in its transformation plan by appointing Barclays Capital Inc. as its exclusive financial advisor. The company is shifting its focus to developing its ...
Hoth said that its legacy biotechnology programs will continue under a wholly owned subsidiary. The company said its shares ...
In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...
Tobi is a crypto writer at Investopedia. He aims to simplify the complex concepts of blockchain and cryptocurrencies for the masses. Julie Bang/ Investopedia More people need better medicines, and ...
Plus: read our predictions for the five hottest AI trends to watch This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...
MaxCyte granted Legend Biotech a non-exclusive worldwide license to use MaxCyte’s Flow Electroporation ® technology and ExPERT™ platform in connection with the research, clinical development, and ...
3T Biosciences spun out of research I and my co-founder, Marvin Gee, did when we were at Stanford in Dr Christopher Garcia's lab. This work was focused on trying to identify targets of T-cell ...
Explore the top five technology trends set to reshape 2025: AI integration, biotech innovations, climate tech, cybersecurity at a global scale, and quantum computing. Unbelievable as it seems, we’re ...
White biotechnology is a key step in a circular economy, enabling the transformation of waste to industrially useful chemicals via a sustainable process. This article delves into two of the key market ...
This biotech firm develops therapies for rare pulmonary diseases, leveraging proprietary drug delivery technology in the U.S. market.